Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides
Por um escritor misterioso
Descrição
The screening, identification, design and clinical application of tumor- specific neoantigens for TCR-T cells, Molecular Cancer
Phage display-identified PD-L1-binding peptides reinvigorate T-cell activity and inhibit tumor progression - ScienceDirect
Frontiers Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies
Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides
(PDF) Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies
Toward a magic or imaginary bullet? Ligands for drug targeting to canc
Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells
Sequences of the tumor homing peptides and their target proteins
Regulation of Signaling from the Epidermal Growth Factor Family
PDF) Novel Cyclic Peptides for Targeting EGFR and EGRvIII Mutation for Drug Delivery
Tumor cell-targeting by phage-displayed peptides
Molecules, Free Full-Text
Design, production, and purification of recombinant EGFRvIII-targeting
PDF) Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype
de
por adulto (o preço varia de acordo com o tamanho do grupo)